The British Society for Haematology (BSH) aims to improve patient care and outcomes in the hematology field. In this interview, 2017/18 BSH President Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, of the University of Birmingham, Birmingham, UK, discusses how the BSH is accelerating improvements in hematology. Prof. Craddock highlights interactions with clinical trials groups, as well as the importance of genomics and big data. This video was recorded at the 2018 BSH Annual Scientific Meeting in Liverpool, UK.
Accelerating assessment of therapies in hematology
